المؤلفون: Schalm, Stefanie S., O’Hearn, Erin, Wilson, Kevin, LaBranche, Timothy P., Silva, Grace, Zhang, Zhuo, DiPietro, Lucian, Bifulco, Neil, Woessner, Richard, Stransky, Nicolas, Sappal, Darshan, Campbell, Robert, Lobbardi, Riadh, Palmer, Michael, Kim, Joseph, Ye, Chaoyang, Dorsch, Marion, Lengauer, Christoph, Guzi, Timothy, Kadambi, Vivek, Garner, Andrew, Hoeflich, Klaus P.

المصدر: In Gastro Hep Advances 2023 2(3):307-321

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schalm SS; Blueprint Medicines Corporation, Cambridge, Massachusetts., O'Hearn E; Blueprint Medicines Corporation, Cambridge, Massachusetts., Wilson K; Blueprint Medicines Corporation, Cambridge, Massachusetts., LaBranche TP; Blueprint Medicines Corporation, Cambridge, Massachusetts., Silva G; Blueprint Medicines Corporation, Cambridge, Massachusetts., Zhang Z; Blueprint Medicines Corporation, Cambridge, Massachusetts., DiPietro L; Blueprint Medicines Corporation, Cambridge, Massachusetts., Bifulco N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Woessner R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Stransky N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Sappal D; Blueprint Medicines Corporation, Cambridge, Massachusetts., Campbell R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lobbardi R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Palmer M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kim J; Blueprint Medicines Corporation, Cambridge, Massachusetts., Ye C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Dorsch M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lengauer C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Guzi T; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kadambi V; Blueprint Medicines Corporation, Cambridge, Massachusetts., Garner A; Blueprint Medicines Corporation, Cambridge, Massachusetts., Hoeflich KP; Blueprint Medicines Corporation, Cambridge, Massachusetts.

المصدر: Gastro hep advances [Gastro Hep Adv] 2022 Nov 08; Vol. 2 (3), pp. 307-321. Date of Electronic Publication: 2022 Nov 08 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: PubMed not MEDLINE